content_top
34 companies, 1 interpreter! Insight, foresight
and recommendation
and recommendation
Osiris Therapeutics, Inc. (OSIR)
0.00
(0.00%)
content_middle
Osiris Therapeutics (OSIR) researches, develops, manufactures, markets, and distributes regenerative medicine products.
OSIR products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chronic wounds, venous leg ulcers, and burns; BIO4, a bone allograft for use in all surgical applications, including spine, trauma, extremity, cranial, and foot and ankle surgery; and Cartiform, a viable chondral allograft that promotes articular cartilage repair to treat focal chondral defects.
Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland.
Previous Close:
5.80
Open:
5.76
Bid:
N/A
Ask:
N/A
1yr Target Price:
4.00
Day's Range:
5.76 - 5.89
52wk Range:
7.01 - 19.30
Volume:
7613
Average Daily Volume:
24675
Market Capitalization:
655.69M
Trailing Annual Dividend Yield:
0.00
Shares Outstanding:
34.53M
content_right
- August 5, 2013 - 9:05am | Earnings
- July 23, 2013 - 8:10am | Research Notes
- July 21, 2013 - 3:49pm | BOD & C-Suite Updates
- July 16, 2013 - 12:20pm | Out and About
- May 7, 2013 - 7:56pm | Out and About
- March 7, 2013 - 9:30am | Earnings
- November 5, 2012 - 10:56am | Earnings
- September 28, 2012 - 8:09am | Research Notes
- September 28, 2012 - 7:56am | Regulatory
- September 20, 2012 - 12:24pm | Research Notes
- August 16, 2012 - 8:08am | Scoreboard at a Glance
- July 31, 2012 - 7:50am | Research Notes
- July 30, 2012 - 8:29am | Earnings
- July 13, 2012 - 8:46am | Research Notes
- July 3, 2012 - 10:07am | Research Notes
- July 3, 2012 - 8:05am | Regulatory
- June 29, 2012 - 7:55am | IP & Patents
- June 14, 2012 - 8:20am | IP & Patents
- June 4, 2012 - 8:07am | Research Notes
- May 30, 2012 - 8:08am | Regulatory